regulation
Six top tips for overcoming pharma’s quality and compliance oversights
September 02 by Pharma IQUncover six quality and compliance mistakes pharma companies are making and what you can do to avoid them
Philippines FDA to speed up Covid-19 clinical trial approval decisions by 50 per cent
February 18 by Emily UwemedimoJanssen among pharma firms being provided increased transparency of regulatory decisions on clinical trial processes in the Philippines
Keeping tabs on Covid-19: Updates on the second Covid-19 vaccine approved in the UK and Bayer’s latest global supply chain infrastructure deal
January 08 by Emily UwemedimoExplore how the pharmaceutical industry is continuing to develop Covid-19 vaccine delivery programs in 2021
Keeping tabs on Covid-19: FDA authorizes restart of AstraZeneca clinical trial and Novavax expands its Maryland manufacturing sites
November 06 by Emily UwemedimoNovavax is expanding its manufacturing campus to support vaccine research and development and business operations
Keeping tabs on Covid-19: FDA approves Veklury as first treatment for Covid-19 and Takeda and Moderna bring 50 million vaccines to Japan
October 30 by Emily UwemedimoSupported by data from three randomized controlled clinical trials, the FDA approves Veklury as the first treatment for hospitalized patients with Covid-19
Balancing regulatory approval with biotech innovation
September 15 by Pharma IQThis Pharma IQ report explores how key players in pharma and biotech are balancing regulation of new drug products while ensuring the industry is able to become more innovative
Virtualizing clinical trials to bring trials closer to patients
September 01 by Pharma IQDive into real-life use cases to discover how clinical research is moving toward more patient-centric models
FDA fronts pivotal life sciences trend in 2020
June 18 by Pharma IQDownload this whitepaper from MasterControl to find out how the FDA's latest digital transformation initiatives will impact life sciences and potentially end the disconnect between innovation and tech...
The roadmap to achieving digital success in pharma
May 27 by Pharma IQAt a time where scalability and supply chain continuity is essential for pharma companies to remain competitive, this report analyzes how to overcome the main challenges of digital transformation in p...
Redefining regulatory compliance in digital health
May 20 by Pharma IQHow new technology models can streamline agile ways of working in healthcare and what a changing digital health landscape means for regulatory approval
Emergent regulatory affairs sphere
September 10 by Pharmaceuticals & Biotechnology EditorThe role of regulatory affairs specialists is oft-overlooked, and the industry needs to adapt to stay within regulations.
Russia’s Pharmaceutical market 2018
June 11 by Adam MusprattIs the Russian pharmaceutical market on course for rapid growth or will it devolve into a market plagued by staleness and drug shortages?